Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
19.04
-0.57 (-2.88%)
Oct 13, 2026, 12:43 PM EDT - Market open
Tyra Biosciences Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Tyra Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $47.45. The average 1-year stock price forecast is 149.28% higher than the current stock price, while the lowest is $29 (+52.35%) and the highest is $59 (+209.96%).
Price Target: $47.45 (+149.28%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tyra Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $59 | Buy | Maintains | $59 | +209.96% | Sep 30, 2026 |
| Raymond James | Raymond James | Buy Maintains $50 | Buy | Maintains | $50 | +162.67% | Sep 24, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $40 | Buy | Reiterates | $50 → $40 | +110.14% | Sep 22, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $50 | Buy | Maintains | $50 | +162.67% | Sep 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $30 → $29 | Buy | Reiterates | $30 → $29 | +52.35% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -2.01
EPS Next Year
-2.77
from -2.64
EPS and Forward PE are based on non-GAAP adjusted numbers.